Publications

View by Year:
 
Hung MS, Chen IC, You L, Jablons DM, Li YC, Mao JH, Xu Z, Lung JH, Yang CT, Liu ST
Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells.
Journal of cellular and molecular medicine, Mar-10-2016;[Epub ahead of print].
Lui NS, Yang YW, van Zante A, Buchanan P, Jablons DM, Lemjabbar-Alaoui H
SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.
PloS one, 2016;[epublish]11(2):e0148911.
Hung MS, Chen IC, You L, Jablons DM, Li YC, Mao JH, Xu Z, Hsieh MJ, Lin YC, Yang CT, Liu ST, Tsai YH
Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells.
Oncology reports, Dec-2015;34(6):3187-95.
Yang YL, Ni J, Hsu PC, Mao JH, Hsieh D, Xu A, Chan G, Au A, Xu Z, Jablons DM, You L
Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.
Journal of cellular and molecular medicine, Oct-2015;19(10):2385-96.  Epub 2015 Jul 27.
Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman JM, Holcatova I, Holly EA, Hoover RN, Hung RJ, Janout V, Key TJ, Kupcinskas J, Kurtz RC, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon RZ, Strobel O, Tavano F, Vashist YK, Vodicka P, Wolpin BM, Yu H, Petersen GM, Risch HA, Klein AP
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
Nature genetics, Aug-2015;47(8):911-6.  Epub 2015 Jun 22.
Wang Y, Xu Z, Mao JH, Hung MS, Hsieh D, Au A, Jablons DM, You L
Analysis of lung tumor initiation and progression in transgenic mice for Cre-inducible overexpression of Cul4A gene.
Thoracic cancer, Jul-2015;6(4):480-7.
Yeh CC, Fan Y, Jiang L, Yang YL, He B, You L, Mann M
Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms.
Anticancer research, Jun-2015;35(6):3167-73.
Wang Y, Xu Z, Mao JH, Hsieh D, Au A, Jablons DM, Li H, You L
PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer.
Zhongguo fei ai za zhi = Chinese journal of lung cancer, Jun-2015;18(6):345-50.
Mo ML, Ma J, Chen Z, Wei B, Li H, Zhou Y, Shi H, Tolani B, Jin JQ, Tseng HH, Shen D, Zhan Y, Li J, Jablons DM, Zhang RQ, Guo Y, He B, Zhou HM
Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer.
Journal of cancer research and clinical oncology, May-2015;141(5):901-8.  Epub 2014 Nov 4.
Blakely CM, Pazarentzos E, Olivas V, Asthana S, Yan JJ, Tan I, Hrustanovic G, Chan E, Lin L, Neel DS, Newton W, Bobb KL, Fouts TR, Meshulam J, Gubens MA, Jablons DM, Johnson JR, Bandyopadhyay S, Krogan NJ, Bivona TG
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.
Cell reports, Apr-7-2015;11(1):98-110.  Epub 2015 Apr 2.
You B, Yang YL, Xu Z, Dai Y, Liu S, Mao JH, Tetsu O, Li H, Jablons DM, You L
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
Oncotarget, Feb-28-2015;6(6):4357-68.
Letteboer TG, Benzinou M, Merrick CB, Quigley DA, Zhau K, Kim IJ, To MD, Jablons DM, van Amstel JK, Westermann CJ, Giraud S, Dupuis-Girod S, Lesca G, Berg JH, Balmain A, Akhurst RJ
Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14.
Frontiers in genetics, 2015;[epublish]6:67.
Woodard GA, Jablons DM
The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling.
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, 2015;e435-41.
Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh TW, Yang C, Tseng HH, Giroux-Leprieur E, Woodard GA, Hao X, Wang C, Jablons DM, He B
EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.
PloS one, 2015;[epublish]10(7):e0132134.
Capelletti M, Dodge ME, Ercan D, Hammerman PS, Park SI, Kim J, Sasaki H, Jablons DM, Lipson D, Young L, Stephens PJ, Miller VA, Lindeman NI, Munir KJ, Richards WG, Jänne PA
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research, Dec-15-2014;20(24):6551-8.  Epub 2014 Oct 7.
[  1  2  3  4  5  6  7  8  9  10  11     View All ]